E-LIB Suche - Ergebnisse für: Tallouzi, Mohammad O.

1

Diabetic retinopathy progression in patients under monitori..:

Haider, Sajjad ; Adderley, Nicola ; Tallouzi, Mohammad O...
BMJ Open. 13 (2023) 4 - p. e073015 , 2023

Link: https://doi.org/10.1136/..

2

Healthcare professionals' views on the most important outco..:

Tallouzi, Mohammad O. ; Moore, David J. ; Bucknall, Nicholas...
PLOS ONE. 18 (2023) 11 - p. e0294117 , 2023

Link: https://doi.org/10.1371/..

3

Outcomes important to patients with non-infectious posterio..:

Tallouzi, Mohammad O ; Moore, David J ; Bucknall, Nicholas...
BMJ Open Ophthalmology. 5 (2020) 1 - p. e000481 , 2020

Link: https://doi.org/10.1136/..

4

COSUMO: study protocol for the development of a core outcom..:

Tallouzi, Mohammad O. ; Mathers, Jonathan M. ; Moore, David J....
Trials. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

5

The effectiveness of pharmacological agents for the treatme..:

Tallouzi, Mohammad O. ; Moore, David J. ; Calvert, Melanie...
Systematic Reviews. 5 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

6

Diabetic retinopathy progression in patients under monitori..:

Haider, Sajjad ; Adderley, Nicola ; Tallouzi, Mohammad O...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083856/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Sudden onset peripheral visual deficit secondary to retinal..:

Ansari, Yousuf ; Kale, Aditya Uday ; Tallouzi, Mohammad O.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871241/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Outcomes important to patients with non-infectious posterio..:

Tallouzi, Mohammad O ; Moore, David J ; Bucknall, Nicholas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375431/. , 2020

Link: http://www.ncbi.nlm.nih...

9

Anti‐tumour necrosis factor biological therapies for the tr..:

Barry, Robert J ; Tallouzi, Mohammad O ; Bucknall, Nick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516996/. , 2018

Link: http://www.ncbi.nlm.nih...

10

COSUMO: study protocol for the development of a core outcom..:

Tallouzi, Mohammad O ; Mathers, Jonathan ; Moore, David J...
Tallouzi , M O , Mathers , J , Moore , D J , Murray , P I , Bucknall , N , Blazeby , J , Calvert , M & Denniston , A 2017 , ' COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis ' , Trials , vol. 18 , no. 576 . https://doi.org/10.1186/s13063-017-2294-8. , 2017

Link: https://hdl.handle.net/1..

11

Anti‐tumour necrosis factor biological therapies for the tr..:

Barry, Robert J ; Bucknall, Nick ; Mathers, Jonathan M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478256/. , 2017

Link: http://www.ncbi.nlm.nih...

12

Healthcare professionals' views on the most important outco..:

Mohammad O Tallouzi ; David J Moore ; Nicholas Bucknall...
https://doi.org/10.1371/journal.pone.0294117. , 2023

Link: https://doi.org/10.1371/..

13

Outcome domains and items identified from the interviews wi..:

Mohammad O. Tallouzi ; David J. Moore ; Nicholas Bucknall...
doi:10.1371/journal.pone.0294117.t002. , 2023

Link: https://doi.org/10.1371/..

14

Questionnaire (interviews):

Mohammad O. Tallouzi ; David J. Moore ; Nicholas Bucknall...
doi:10.1371/journal.pone.0294117.s001. , 2023

Link: https://doi.org/10.1371/..

15

Interviewee details:

Mohammad O. Tallouzi ; David J. Moore ; Nicholas Bucknall...
doi:10.1371/journal.pone.0294117.t001. , 2023

Link: https://doi.org/10.1371/..